1. Three-year outcome in a patient with Staphylococcus lugdunensis discitis.
- Author
-
Camacho M, Guis S, Mattei JP, Costello R, and Roudier J
- Subjects
- Aged, Anti-Bacterial Agents therapeutic use, Anti-Infective Agents therapeutic use, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Discitis drug therapy, Discitis etiology, Humans, Immunocompromised Host, Lumbar Vertebrae microbiology, Male, Microbial Sensitivity Tests, Multiple Myeloma drug therapy, Multiple Myeloma immunology, Ofloxacin therapeutic use, Pristinamycin therapeutic use, Staphylococcal Infections complications, Staphylococcal Infections drug therapy, Staphylococcus isolation & purification, Discitis pathology, Lumbar Vertebrae pathology, Staphylococcal Infections pathology
- Abstract
The few reported cases of bone and joint infection by Staphylococcus lugdunensis indicate that the clinical manifestations are severe, the diagnosis elusive, and the treatment difficult. We report a case of lumbar discitis caused by Staphylococcus lugdunensis in a 67-year-old man receiving chemotherapy for stage III IgA lambda multiple myeloma. Treatment was with ofloxacin and pristinamycin for 1 year. Although he started to improve only 5 months after treatment initiation, the outcome was favorable. Follow-up at the time of this writing is 3 years.
- Published
- 2002
- Full Text
- View/download PDF